secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001753926-25-000851
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q1 revenues $8.3M, net loss $2.6M vs. net income $2.3M year ago; forecasts profitability rest of year
--------------------------------------------------------------------------------

- Revenue $8.3M, down 22% YoY from $10.7M; net loss $0.16 per share vs. net income $0.14 per diluted share.
- Gross margin 53.0% vs. 62.6% year ago due to lower sales and higher service costs.
- Shipped 21 SRT systems, including 15 to a large customer; treatment volume from FDAs increased 65% sequentially.
- Management expects profitability in each of next three quarters and full year; affirms 3-5 additional multisite FDA customers this year.
- R&D expense $2.6M vs. $0.9M driven by lobbying costs for billing code reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000175392625000851/0001753926-25-000851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000175392625000851/g084817_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer